Last reviewed · How we verify
Randomized Controlled Clinical Trial to Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic Children
The purpose of this project is to evaluate in a randomized clinical trial, double-blind, controlled, the effects of a dietary supplement containing Lactobacillus reuteri DSM 17938 and vitamin D3 in reducing bronchial inflammation and improve asthma control in patients in children with mild / moderate persistent asthma .
Details
| Lead sponsor | University of Campania Luigi Vanvitelli |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 52 |
| Start date | 2014-04 |
| Completion | 2016-03 |
Conditions
- Asthma
Interventions
- Reuterin D3 drops
- Placebo
Primary outcomes
- Reduction of allergic bronchial inflammation — Up to 3 months
Reduction of FeNO values - Reduction of allergic bronchial inflammation — Up to 3 months
Reduction of a series of markers of bronchial inflammation: IL-2; IL-4; IL-10; IFN-γ.
Countries
Italy